EHS
EHS

New patent for Genentech Inc drug GAVRETO – DrugPatentWatch


Copyright © DrugPatentWatch. Originally published at New patent for Genentech Inc drug GAVRETO


Annual Drug Patent Expirations for GAVRETO

Gavreto is a drug marketed by Genentech Inc and is included in one NDA. It is available from one supplier. There is one patent protecting this drug.

This drug has twenty-four patent family members in twenty countries.

The generic ingredient in GAVRETO is pralsetinib. One supplier is listed for this compound. Additional details are available on the pralsetinib profile page.

For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com

Make Better Decisions with DrugPatentWatch

» Start Your Free Trial Today «

Copyright © DrugPatentWatch. Originally published at New patent for Genentech Inc drug GAVRETO



Source link

EHS
Back to top button